AQB vs. OBSV, MEDS, CYCN, GRAY, OSA, TRVN, VAXX, BNOX, XWEL, and PBM
Should you be buying AquaBounty Technologies stock or one of its competitors? The main competitors of AquaBounty Technologies include ObsEva (OBSV), TRxADE HEALTH (MEDS), Cyclerion Therapeutics (CYCN), Graybug Vision (GRAY), ProSomnus (OSA), Trevena (TRVN), Vaxxinity (VAXX), Bionomics (BNOX), XWELL (XWEL), and Psyence Biomedical (PBM).
ObsEva (NASDAQ:OBSV) and AquaBounty Technologies (NASDAQ:AQB) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, community ranking and earnings.
In the previous week, AquaBounty Technologies had 11 more articles in the media than ObsEva. MarketBeat recorded 11 mentions for AquaBounty Technologies and 0 mentions for ObsEva. AquaBounty Technologies' average media sentiment score of 0.00 beat ObsEva's score of -0.35 indicating that ObsEva is being referred to more favorably in the media.
ObsEva received 135 more outperform votes than AquaBounty Technologies when rated by MarketBeat users. However, 64.34% of users gave AquaBounty Technologies an outperform vote while only 53.52% of users gave ObsEva an outperform vote.
17.5% of ObsEva shares are owned by institutional investors. Comparatively, 8.9% of AquaBounty Technologies shares are owned by institutional investors. 14.4% of ObsEva shares are owned by insiders. Comparatively, 2.3% of AquaBounty Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
AquaBounty Technologies has a consensus target price of $25.00, indicating a potential upside of 1,215.79%.
ObsEva has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, AquaBounty Technologies has a beta of 1.31, indicating that its stock price is 31% more volatile than the S&P 500.
ObsEva has a net margin of 0.00% compared to ObsEva's net margin of -1,263.43%. ObsEva's return on equity of -16.07% beat AquaBounty Technologies' return on equity.
AquaBounty Technologies has lower revenue, but higher earnings than ObsEva. AquaBounty Technologies is trading at a lower price-to-earnings ratio than ObsEva, indicating that it is currently the more affordable of the two stocks.
Summary
ObsEva beats AquaBounty Technologies on 8 of the 14 factors compared between the two stocks.
Get AquaBounty Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for AQB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AQB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AquaBounty Technologies Competitors List
Related Companies and Tools
